Structural insights into the broad-spectrum antiviral target endoplasmic reticulum alpha-glucosidase II
Targeting the host-cell endoplasmic reticulum quality control (ERQC) pathway is an effective broad-spectrum antiviral strategy. The two ER resident α-glucosidases whose sequential action permits entry in this pathway are the targets of glucomimetic inhibitors. Knowledge of the molecular details of t...
Príomhchruthaitheoirí: | Zitzmann, N, Caputo, AT, Alonzi, DS, Kiappes, JL, Struwe, WB, Cross, A, Basu, S, Darlot, B, Roversi, P |
---|---|
Rannpháirtithe: | Hilgenfeld, R |
Formáid: | Book section |
Teanga: | English |
Foilsithe / Cruthaithe: |
Springer
2018
|
Míreanna comhchosúla
-
Structural studies of Endoplasmic Reticulum Glucosidase II
de réir: Caputo, A, et al.
Foilsithe / Cruthaithe: (2015) -
Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals
de réir: Caputo, A, et al.
Foilsithe / Cruthaithe: (2016) -
Investigating the inhibition of endoplasmic reticulum α-Glucosidase II for the development of broad-spectrum antivirals
de réir: Bremner, FR
Foilsithe / Cruthaithe: (2023) -
ToP-DNJ, a selective inhibitor of endoplasmic reticulum α-glucosidase II exhibiting anti-flaviviral activity
de réir: Kiappes, JL, et al.
Foilsithe / Cruthaithe: (2017) -
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
de réir: Warfield, KL, et al.
Foilsithe / Cruthaithe: (2016)